Brief: Trinity Biotech - Enters ATM Offering Agreement With Lucid Capital Markets For ADS Sale - SEC Filing
12/06/2026 21:29
BRIEF-Trinity Biotech - Enters ATM Offering Agreement With Lucid Capital Markets For ADS Sale - SEC Filing June 12 (Reuters) - Trinity Biotech PLC TRIB.O:
TRINITY BIOTECH - ENTERS ATM OFFERING AGREEMENT WITH LUCID CAPITAL MARKETS FOR ADS SALE - SEC FILING
TRINITY BIOTECH - MAY OFFER AND SELL ADSS UP TO $4.35 MILLION THROUGH LUCID - SEC FILING
Source text: [ID:n0001554855-26-001320]
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsIreland's Trinity Biotech Q1 revenue rises on HIV test sales
Brief: Trinity Biotech - Enters ATM Offering Agreement With Lucid Capital Markets For ADS Sale - SEC Filing
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla
Trinity Biotech rises as prostate cancer test shows strong accuracy